Loading...
Loading...
Below are the top diagnostic substances stocks on the NASDAQ in terms of return on assets.
The trailing-twelve-month return on assets at Meridian Bioscience
VIVO is 21.50%. Meridian Bioscience's revenue for the same period is $188.10 million.
The trailing-twelve-month return on assets at IDEXX Laboratories
IDXX is 19.70%. IDEXX Laboratories' operating margin for the same period is 19.40%.
The trailing-twelve-month return on assets at Neogen
NEOG is 15.90%. Neogen's EPS for the same period is $0.75.
The trailing-twelve-month return on assets at SurModics
SRDX is 14.30%. SurModics' PEG ratio is 1.57.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in